Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
1,022,530
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
222,867
-
Shares change
-
+35,827
-
Total reported value, excl. options
-
$518,348
-
Value change
-
+$50,174
-
Number of buys
-
8
-
Number of sells
-
3
-
Price
-
$2.38
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) as of Q3 2023
As of 30 Sep 2023 Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 222,867 shares of stock of the company.
Largest 10 holders included AdvisorShares Investments LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), ACADIAN ASSET MANAGEMENT LLC, UBS Group AG, OSAIC HOLDINGS, INC., GROUP ONE TRADING, L.P., and BANK OF AMERICA CORP /DE/.
This table shows 14 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.